Structural analysis of four and half LIM protein-2 in dilated cardiomyopathy

被引:44
作者
Arimura, Takuro
Hayashi, Takeharu
Matsumoto, Yuji
Shibata, Hiroki
Hiroi, Shitoshi
Nakamura, Takeyuki
Inagaki, Natsuko
Hinohara, Kunihiko
Takahashi, Megumi
Manatsu, Satoh-Itoh
Sasaoka, Taishi
Izumi, Toru
Bonne, Gisele
Schwartz, Ketty
Kimura, Akinori [1 ]
机构
[1] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pathogenesis, Tokyo 1010062, Japan
[2] Kitazato Univ, Sch Med, Dept Internal Med & Cardiol, Kanagawa 2258555, Japan
[3] INSERM, U582, Inst Myol, F-75013 Paris, France
[4] Univ Paris 06, Fac Med, F-75013 Paris, France
[5] Grp Hosp Pitie Salpetriere, AP HP, UF Myogenet & Cardiogenet, Serv Biochim B, F-75013 Paris, France
关键词
dilated cardiomyopathy; four and half LIM protein 2; titin/connectin; mutation;
D O I
10.1016/j.bbrc.2007.03.128
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dilated cardiomyopathy (DCM) is a cardiac disease characterized by dilated ventricle and systolic dysfunction. Most of the DCM patients are sporadic cases, but a certain population of DCM patients can be familial cases caused by mutations in genes for sarcomere/Z-disc components including titin/connectin. However, disease-causing mutations could be identified only in a part of the familial DCM patients, suggesting that there should be other disease causing genes for DCM. To explore a novel disease gene for DCM, we searched for mutations in FHL2, encoding for four and half LIM protein 2 (FHL2) in DCM patients, because FHL2 is known to associate with titin/connectin. A missense mutation, Gly48Ser, was identified in a patient with familial DCM. Functional analysis demonstrated that the FHL2 mutation affected the binding to titin/connectin. Because FHL2 protein is known to tether metabolic enzymes to titin/connectin, these observations suggest that the Gly48Ser mutation may be involved in the pathogenesis of DCM via impaired recruitment of metabolic enzymes to the sarcomere. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:162 / 167
页数:6
相关论文
共 27 条
[1]   MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure [J].
Arber, S ;
Hunter, JJ ;
Ross, J ;
Hongo, M ;
Sansig, G ;
Borg, J ;
Perriard, JC ;
Chien, KR ;
Caroni, P .
CELL, 1997, 88 (03) :393-403
[2]   A Cypher/ZASP mutation associated with dilated cardiomyopathy alters the binding affinity to protein kinase C [J].
Arimura, T ;
Hayashi, T ;
Terada, H ;
Lee, SY ;
Zhou, Q ;
Takahashi, M ;
Ueda, K ;
Nouchi, T ;
Hohda, S ;
Shibutani, M ;
Hirose, M ;
Chen, J ;
Park, JE ;
Yasunami, M ;
Hayashi, H ;
Kimura, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (08) :6746-6752
[3]   Molecular cloning and characterization of FHL2, a novel LIM domain protein preferentially expressed in human heart [J].
Chan, KK ;
Tsui, SKW ;
Lee, SMY ;
Luk, SCW ;
Liew, CC ;
Fung, KP ;
Waye, MMY ;
Lee, CY .
GENE, 1998, 210 (02) :345-350
[4]   Novel mutations in sarcomeric protein genes in dilated cardiomyopathy [J].
Daehmlow, S ;
Erdmann, J ;
Knueppel, T ;
Gille, C ;
Froemmel, C ;
Hummel, M ;
Hetzer, R ;
Regitz-Zagrosek, V .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 298 (01) :116-120
[5]   Cardiac myosin binding protein C - Its role in physiology and disease [J].
Flashman, E ;
Redwood, C ;
Moolman-Smook, J ;
Watkins, H .
CIRCULATION RESEARCH, 2004, 94 (10) :1279-1289
[6]   Subtractive cloning and characterization of DRAL, a novel LIM-domain protein down-regulated in rhabdomyosarcoma [J].
Genini, M ;
Schwalbe, P ;
Scholl, FA ;
Remppis, A ;
Mattei, MG ;
Schafer, BW .
DNA AND CELL BIOLOGY, 1997, 16 (04) :433-442
[7]   The giant protein titin - A major player in myocardial mechanics, signaling, and disease [J].
Granzier, HL ;
Labeit, S .
CIRCULATION RESEARCH, 2004, 94 (03) :284-295
[8]   Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy [J].
Hayashi, T ;
Arimura, T ;
Itoh-Satoh, M ;
Ueda, K ;
Hohda, S ;
Inagaki, N ;
Takahashi, M ;
Hori, H ;
Yasunami, M ;
Nishi, H ;
Koga, Y ;
Nakamura, H ;
Matsuzaki, M ;
Choi, BY ;
Bae, SW ;
You, CW ;
Han, KH ;
Park, JE ;
Knöll, R ;
Hoshijima, M ;
Chien, KR ;
Kimura, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (11) :2192-2201
[9]   αB-crystallin mutation in dilated cardiomyopathy [J].
Inagaki, N ;
Hayashi, T ;
Arimura, T ;
Koga, Y ;
Takahashi, M ;
Shibata, H ;
Teraoka, K ;
Chikamori, T ;
Yamashina, A ;
Kimura, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 342 (02) :379-386
[10]   Titin mutations as the molecular basis for dilated cardiomyopathy [J].
Itoh-Satoh, M ;
Hayashi, T ;
Nishi, H ;
Koga, Y ;
Arimura, T ;
Koyanagi, T ;
Takahashi, M ;
Hohda, S ;
Ueda, K ;
Nouchi, T ;
Hiroe, M ;
Marumo, F ;
Imaizumi, T ;
Yasunami, M ;
Kimura, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 291 (02) :385-393